Log in to save to my catalogue

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7c89c439660d4b74aabbd1c24759f275

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

About this item

Full title

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2022-09, Vol.7 (1), p.331-27, Article 331

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Cancers are highly complex diseases that are characterized by not only the overgrowth of malignant cells but also an altered immune response. The inhibition and reprogramming of the immune system play critical roles in tumor initiation and progression. Immunotherapy aims to reactivate antitumor immune cells and overcome the immune escape mechanisms...

Alternative Titles

Full title

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7c89c439660d4b74aabbd1c24759f275

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7c89c439660d4b74aabbd1c24759f275

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-022-01136-2

How to access this item